影响新疗法的发展
IQVIA is helping the world’s leading patient advocacy associations in their efforts to accelerate the development of new treatments and elevate the quality of patient care.
Discover IQVIA’s Registry Solutions
Access IQVIA's industry-leading technology and full range of services, from strategic consulting and program design, to technology support and quality assurance. Our registry solutions can be designed to meet the needs of your members, and support both practice improvement and the promotion of research:
- Multi-tenant architecture, data modeling, and robust data warehousing,允许您在单个平台上操作多个注册表和子研究
- 直观的基于Web的接口minimizes training requirements and creates consistency across registry programs
- 患者报告的结果designed for desktop or mobile use, simplifies the collection of high-quality real world data
- Master patient indexenables cross-registry analysis, reporting, and longitudinal tracking
- Advanced EHR and medical device integration capabilities减轻数据进入负担并消除参与障碍
Proud to be a partner
IQVIA's experts have extensive experience designing and deploying registries for some of the most prominent patient associations and medical specialty societies.
- The Cystic Fibrosis Foundation’s CF Patient Registry,hosted on an IQVIA technology platform, helps caregivers and researchers identify new health trends, spot effective treatments, and design clinical trials.
- American Heart Association/American Stroke Association’sGet with the Guidelines® program is hosted on technology provided by IQVIA, and impacts more than 80,000 patients annually.
- The American College of Surgeons(ACS) uses IQVIA’s Registry Platform to deploy multiple patient registries with robust metrics that improve the quality of surgical care.
- 医疗研究和质量机构lol买外围用什么软件(AHRQ) and IQVIA partnered to build a landmark guidebook on patient registries, with specialized guidance for rare disease registries.
Optimizing Insulin Use Through Smart Pens: Challenges and Opportunities in Europe
Planning for Registry Success
Engage with us
正在进行的数据管理技术可用于确保长期数据质量，但是首先，您的组织必须定义数据质量对您的专业意味着什么。您的组织将如何牢记最终的计划，并满足越来越多的想要利用数据的用户的监管，研究和信息学需求？
This white paper examines how registries can provide a valuable foundation for multi-arm, multi-company trials by fostering long-term, collaborative relationships between rare disease stakeholders and improving our understanding of diseases and treatment outcomes.